Tadashi Iso

This inventor holds 33 USPTO granted patents, primarily in Sulfur-Containing Compounds. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 1979-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadashi Iso. Retrieved from https://idiyas.com/inventor/tadashi-iso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 162(Granted Patents)

Location History:

Kyoto, JP (1984)
Tondabayashi, JP (1979 - 1985)
Sakai, JP (1984 - 1988)
Kawachinagano, JP (1991 - 1994)

Company Filing History:

33 out of 282

Santen Pharmaceutical Co., Ltd.

patents

Years Active: 1979-1994

Loading Chart...

Areas of Expertise:

Cysteine Derivatives

Cyclic Sulfur-Containing Compounds

Benzothiazine Derivatives

Antihypertensive Agents

Disulfide Compounds

Five-Membered Heterocyclic Compounds

Platelet Anti-Aggregative

Thiazolidine Compounds

Cardiovascular Treatments

Ophthalmics

Carbonyl Group Compounds

Rheumatism Treatment

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5292926 - Cysteine derivatives (1994-03-08),

2. 5153198 - Agent for treatment of disorders of the cerebro-neural transmission (1992-10-06),

3. 5128467 - Cyclic sulfur-containing compounds (1992-07-07),

4. 5087627 - Agent for treatment of disorders of the cerebro-neural transmission (1992-02-11),

5. 5082836 - Compositions and methods of use of cyclic sulfur-containing compounds (1992-01-21),

6. 5041435 - Cyclic sulfur-containing compounds (1991-08-20),

7. 5034230 - Anti-allergic ophthalmics (1991-07-23),

8. 4786635 - Novel benzothiazine derivatives (1988-11-22),

9. 4584300 - Platelet anti-aggregative- and calcium antagonistic (1986-04-22),

10. 4558125 - Benzothiazoline compounds which contain a carbonyl group useful for (1985-12-10),

11. 4552969 - 3-Alkanoyl benzothiazoline compounds useful for treating cardiovascular (1985-11-12),

12. 4552765 - Aletheine derivatives (1985-11-12),

13. 4547513 - 2-Arylbenzothiazoline derivatives and their use in treating angina cordis (1985-10-15),

14. 4517123 - Cysteine derivatives of disulfide form (1985-05-14),

15. 4499102 - Thiazolidine and pyrrolidine compounds and pharmaceutical compositions (1985-02-12),

Title: Tadashi Iso: Innovator in Immunomodulation and Neurological Treatments

Introduction

Tadashi Iso, based in Sakai, Japan, is a prominent inventor with a remarkable portfolio of 33 patents. His contributions to the field of pharmaceuticals, particularly in immunomodulation and treatments for neurological disorders, have significantly advanced medical science.

Latest Patents

Among his latest inventions, Iso has developed cysteine derivatives that serve as immunomodulators and provide treatment for liver disorders. These compounds are defined by a specific formula and are noted for their potential medicinal benefits. Another recent patent includes a compound aimed at treating disorders of cerebro-neural transmission, providing a promising solution for various neurological issues.

Career Highlights

Iso is currently affiliated with Santen Pharmaceutical Co., Ltd., a company dedicated to the development of innovative eye care solutions. His work at Santen has been instrumental in advancing the company's research and development initiatives, particularly in the areas of immunology and neurology.

Collaborations

Throughout his career, Iso has collaborated with notable colleagues such as Masayuki Oya and Jun-ichi Iwao. These partnerships have enriched his research activities, fostering an environment of innovation and shared expertise.

Conclusion

Tadashi Iso continues to be a vital player in the realm of pharmaceutical innovation. His extensive patent portfolio and collaborative efforts showcase his commitment to enhancing healthcare solutions, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]